Cargando…

Sjogren’s Syndrome: Recent Updates

Detalles Bibliográficos
Autores principales:	Skarlis, Charalampos, Raftopoulou, Sylvia, Mavragani, Clio P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778847/ https://www.ncbi.nlm.nih.gov/pubmed/35054094 http://dx.doi.org/10.3390/jcm11020399

Ejemplares similares

Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren’s Syndrome
por: Skarlis, Charalampos, et al.
Publicado: (2022)

Study of the incidence of osteoporosis in patients with Sjögren’s syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system
por: Skarlis, Charalampos, et al.
Publicado: (2018)

Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis
por: Nezos, Adrianos, et al.
Publicado: (2015)

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies
por: Skarlis, Charalampos, et al.
Publicado: (2023)

+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications
por: Skarlis, Charalampos, et al.
Publicado: (2021)

Editorial: Management of Sjögren's Syndrome
por: Alunno, Alessia, et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?
por: Nezos, Adrianos, et al.
Publicado: (2021)

Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use
por: Fragkioudaki, Sofia, et al.
Publicado: (2016)

Atherosclerosis in SLE: a potential role for serum parathormone levels
por: Giannelou, Mayra, et al.
Publicado: (2020)

Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes
por: Georgakopoulou, Vasiliki E., et al.
Publicado: (2022)

The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement
por: Raftopoulou, Sylvia, et al.
Publicado: (2022)

Musculoskeletal Manifestations in Sjogren’s Syndrome: An Orthopedic Point of View
por: Rozis, Meletios, et al.
Publicado: (2021)

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity
por: Karathanasis, Dimitris K., et al.
Publicado: (2022)

Vitamin D Deficiency in Primary Sjögren’s Syndrome: Association with Clinical Manifestations and Immune Activation Markers
por: Athanassiou, Panagiotis, et al.
Publicado: (2022)

TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients
por: Nezos, Adrianos, et al.
Publicado: (2018)

Predicting the Outcome of Sjogren’s Syndrome-Associated Non-Hodgkin’s Lymphoma Patients
por: Papageorgiou, Aristea, et al.
Publicado: (2015)

TLR7 Signaling Drives the Development of Sjögren’s Syndrome
por: Wang, Yawen, et al.
Publicado: (2021)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
por: Koulouri, Vasiliki, et al.
Publicado: (2022)

Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals
por: Mavragani, Clio P., et al.
Publicado: (2022)

Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations
por: Gravani, Fotini, et al.
Publicado: (2015)

Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome
por: Flessa, Christina-Maria, et al.
Publicado: (2022)

A case of antisynthetase syndrome
por: Mavragani, Clio P., et al.
Publicado: (2020)

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome
por: Fragkioudaki, Sofia, et al.
Publicado: (2017)

Update on Sjögren’s Syndrome 2018
por: Argyropoulou, Ourania D., et al.
Publicado: (2018)

Adult Onset Still's Disease and Autoinflammation
por: Efthimiou, Petros, et al.
Publicado: (2012)

Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome
por: Argyriou, Evangelia, et al.
Publicado: (2021)

IL-21 and Sjögren's syndrome
por: Scofield, R Hal
Publicado: (2011)

Review of autoantigens in Sjögren’s syndrome: an update
por: Tong, Louis, et al.
Publicado: (2017)

Recent advances in primary Sjogren's syndrome
por: Holdgate, Nicholas, et al.
Publicado: (2016)

Editorial: Demyelinating neurological syndromes: The role of autoimmunity
por: Evangelopoulos, Maria Eleftheria, et al.
Publicado: (2023)

Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome
por: Fava, Roy A, et al.
Publicado: (2011)

Pathogenesis and treatment of Sjogren’s syndrome: Review and update
por: Zhan, Qipeng, et al.
Publicado: (2023)

Stratifying primary Sjögren’s syndrome: killers in the balance?
por: Bowman, Simon J., et al.
Publicado: (2015)

Recent Advances in Mouse Models of Sjögren's Syndrome
por: Gao, Yunzhen, et al.
Publicado: (2020)

Recent Advances in the Use of Exosomes in Sjögren’s Syndrome
por: Huang, Yupeng, et al.
Publicado: (2020)

Genetic control of disease in an experimental model for Sjögren's syndrome
por: Andersson, Åsa
Publicado: (2009)

Mechanisms of Disease in Sjögren Syndrome—New Developments and Directions
por: de Paiva, Cintia S., et al.
Publicado: (2020)

Prevalence and Clinical Implications of Scleroderma-Specific Autoantibodies in Seronegative Patients with Sicca Complaints
por: Marketos, Nikolaos, et al.
Publicado: (2023)

Recent Advances of Salivary Gland Biopsy in Sjögren's Syndrome
por: Liao, Rui, et al.
Publicado: (2022)

Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development
por: Goules, Andreas V., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e3dsuu0q97n84gruqi6kersi6q